相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients
Yoshinori Shimamoto et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M. Weber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Epidemiology of multiple myeloma in Taiwan - Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years
Shang-Yi Huang et al.
CANCER (2007)
Patterns of survival in multiple myeloma:: A population-based study of patients diagnosed in Sweden from 1973 to 2003
Sigurdur Yngvi Kristinsson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Extramedullary disease and targeted therapies for hematological malignancies - is the association real?
P. Raanani et al.
ANNALS OF ONCOLOGY (2007)
Extramedullary relapse of multiple myeloma associated with a shift in secretion from intact immunoglobulin to light chains
Mark A. Dawson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Bortezomib:: an effective agent in extramedullary disease in multiple myeloma
R Laura et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients
JA Pérez-Simón et al.
LEUKEMIA (2006)
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the eastern cooperative oncology group
SV Rajkumar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma
E Terpos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome
R Zeiser et al.
BONE MARROW TRANSPLANTATION (2004)
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center
G Damaj et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Allogeneic transplantation for multiple myeloma: late relapse may occur as localised lytic lesion/plasmacytoma despite ongoing molecular remission
JL Byrne et al.
BONE MARROW TRANSPLANTATION (2003)
Lack of response to thalidomide in plasmacytomas
B Myers et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma
A Avigdor et al.
LEUKEMIA & LYMPHOMA (2001)
Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas
J Bladé et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy
G Chong et al.
BONE MARROW TRANSPLANTATION (2000)
Late and localized extramedullary relapse of a light chain kappa myeloma after syngeneic bone marrow transplantation
F Trullemans et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
